RTTNews | Feb 8, 2021 10:00AM EST

10:00 Monday, February 8, 2021 (RTTNews.com) - CollPlant Biotechnologies Ltd. (CLGN) are currently gaining over 10% after the company said it entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.

CLGN is currently trading at $20.26, up $2.05 or 11.26%, on the Nasdaq.

CollPlant will receive an upfront payment of $14 million and is entitled to receive up to an additional $89 million in milestone payments. In addition, CollPlant is eligible to receive royalty payments and a fee for the manufacture and supply of rhCollagen to Allergan Aesthetics.

Read the original article on RTTNews ( https://www.rttnews.com/3167808/stock-alert-collplant-biotech-gains-10-on-agreement-with-allergan.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved